Association between albumin changes and prognosis in older patients with acute myocardial infarction

Zhicheng Yang, Lei Zhang, Ying‐Bin Xi, Guihua Jiang, Lin He, Hui Pan, Zhi‐Hao WangFrontiers in Medicine 2025 · DOI

Abstract

Our findings showed an S-shaped association between albumin changes and mortality in older patients with acute myocardial infarction (AMI), with inflection points at approximately -3.27 g/L and 0.92 g/L. Furthermore, changes in albumin levels were negatively correlated with the incidence of gastrointestinal bleeding and acute heart failure. These results provide valuable insights for clinical treatment strategies in geriatric cardiology.

Introduction

Acute myocardial infarction (AMI) remains a primary cause of mortality globally, particularly among older adults. While serum albumin is a well-established marker for nutritional status and inflammation, clinical assessments typically rely on a single "snapshot" measurement taken at admission. However, AMI is a dynamic physiological event; complications such as heart failure or renal stress can rapidly alter plasma volume and hepatic synthesis, leading to significant fluctuations in albumin levels during hospitalization. This study investigates whether the trajectory of these changes offers superior prognostic value compared to static baseline readings.

Methods and Data

The researchers conducted a retrospective observational study using clinical data from the Department of Cardiology at Shandong University Qilu Hospital, spanning September 2017 to March 2022.

Study Population

The initial pool consisted of 3,235 patients. After applying exclusion criteria—including age under 65, pre-existing complex cardiac conditions (e.g., endocarditis, valvular disease), and missing albumin data—a final cohort of 288 patients was established.

Flowchart of participant enrollment and exclusion criteria.

Statistical Analysis

Albumin change was defined as the difference between the average level during hospitalization and the level at admission. To analyze non-linear relationships, restricted cubic splines (RCS) were integrated into multivariable-adjusted Cox regression models. These models were adjusted for a wide range of covariates, including BMI, comorbidities (diabetes, hypertension, stroke), and pharmacological interventions (statins, antiplatelets, anticoagulants).

Results

The study revealed a significant non-linear, S-shaped relationship between albumin fluctuations and patient mortality.

The S-Curve and Inflection Points

The risk of mortality does not follow a linear path. For all-cause mortality, critical inflection points were identified at -3.27 g/L and 0.92 g/L. Between these points, the Odds Ratio (OR) for all-cause death was 2.12, indicating a peak risk zone.

Restricted cubic spline models showing the S-shaped relationship between albumin changes and mortality risk (all-cause and cardiac death) across three adjustment models.

Secondary Clinical Outcomes

Beyond mortality, albumin changes demonstrated a negative correlation with major complications:

  • Gastrointestinal (GI) Hemorrhage: OR 0.87 (95% CI: 0.81–0.94, p < 0.001).
  • Acute Heart Failure (AHF): OR 0.86 (95% CI: 0.75–0.99, p = 0.046).

In patients over 75, an increase in albumin levels was particularly protective against these complications, likely due to improved oncotic pressure and vascular stability.

Discussion and Conclusion

These findings suggest that albumin is more than a nutritional proxy; it serves as a functional indicator of vascular integrity and antioxidant capacity during the acute phase of AMI. Significant drops in albumin (exceeding 3.27 g/L) signal a failure in compensatory mechanisms, identifying high-risk patients who may benefit from targeted monitoring or albumin supplementation.

Limitations

The study's retrospective nature and high exclusion rate due to missing data (nearly 750 patients) may limit generalizability. Future prospective, multi-center trials are necessary to validate these inflection points and determine if proactive albumin management can directly improve survival rates in the older AMI population.

Summary updated

Abstract

Out findings showed that a S-shaped association between the albumin changes and mortality of older AMI patients, with the inflection of roughly -3.27 g/L and 0.92/L. And changes in albumin levels are negatively correlated with gastrointestinal bleeding and acute heart failure. These findings were helpful for the clinical treatment.
BibTeX
@inproceedings{yang2025association,
  author = {Zhicheng Yang and Lei Zhang and Ying‐Bin Xi and Guihua Jiang and Lin He and Hui Pan and Zhi‐Hao Wang},
  title = {{Association between albumin changes and prognosis in older patients with acute myocardial infarction}},
  booktitle = {Frontiers in Medicine},
  year = {2025},
  doi = {10.3389/fmed.2024.1508868},
}
Figure